thiazolyl blue has been researched along with cerulenin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Colomer, R; Lupu, R; Menendez, JA | 1 |
| Chi-Ming Chiu, L; Eng-Choon Ooi, V; Ho, TS; Ho, YP; Wong, WY; Wong, YS | 1 |
2 other study(ies) available for thiazolyl blue and cerulenin
| Article | Year |
|---|---|
Inhibition of tumor-associated fatty acid synthase activity enhances vinorelbine (Navelbine)-induced cytotoxicity and apoptotic cell death in human breast cancer cells.
Topics: Antifungal Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Cerulenin; Coloring Agents; DNA; Dose-Response Relationship, Drug; Drug Synergism; Fatty Acid Synthases; Humans; Inhibitory Concentration 50; Tetrazolium Salts; Thiazoles; Time Factors; Vinblastine; Vinorelbine | 2004 |
Fatty acid synthase inhibitors cerulenin and C75 retard growth and induce caspase-dependent apoptosis in human melanoma A-375 cells.
Topics: 4-Butyrolactone; Antineoplastic Agents; Apoptosis; Blotting, Western; Caspases; Cell Cycle; Cell Line, Tumor; Cerulenin; DNA, Neoplasm; Enzyme Inhibitors; fas Receptor; Fatty Acid Synthases; Flow Cytometry; Genes, bcl-2; Humans; Melanoma; Microscopy, Confocal; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasm Proteins; Proto-Oncogene Proteins c-bcl-2; Tetrazolium Salts; Thiazoles | 2007 |